Drug modulation of activity of microRNA generation in functional disorders of the gallbladder and sphincter of Oddi in children
Journal Title: Здоров`я дитини - Year 2019, Vol 14, Issue 2
Abstract
Background. Functional disorders of the gallbladder and sphincter of Oddi are highly relevant in pediatric gastroenterology. The purpose of the study was to improve the treatment for functional disorders of the gallbladder and sphincter of Oddi in children based on studying the activity of microRNA generation. Materials and methods. Seventy children with functional disorders of the gallbladder and sphincter of Oddi were examined. Fifty patients received standard therapy in combination with ursodeoxycholic acid as a suspension formulation of Ukrliv®, and 20 patients received standard therapy without ursodeoxycholic acid. Prior to treatment and after the end of therapy, a molecular genetic study was carried out in all children to determine the level of microRNA-378f, microRNA-4311, microRNA-4714-3p expression in the blood serum using real time polymerase chain reaction. Results. It was found that in children with functional disorders of the gallbladder and sphincter of Oddi after the treatment with ursodeoxycholic acid, there was a probable decrease in the levels of aspartate aminotransferase from 34.96 ± 1.31 n/l to 26.18 ± 0.97 n/l, alkaline phosphatase from 507.92 ± 19.94 n/l to 359.53 ± 16.59 n/l in the blood serum and an increase in the contractile function of the gallbladder from 23.44 ± 1.56 % to 45.56 ± 1.68 % (p < 0.05). It was found that after standard therapy in combination with ursodeoxycholic acid (Ukrliv® suspension) in children with functional disorders of the gallbladder and sphincter of Oddi, the level of microRNA-378f expression was close to 5.23 ± 0.70 c.u., which was statistically significantly higher than before therapy (p < 0.05). On the background of standard therapy with and without the addition of ursodeoxycholic acid, the expression profile of micro-RNA-4714-3p in the blood serum of the examined children from groups 1 and 2 decreased significantly sharply to the level of 1.93 ± 0.58 c.u. and 1.14 ± 0.53 c.u., respectively (p < 0.05). Conclusions. The findings showed that under the influence of ursodeoxycholic acid, clinical and paraclinical manifestations of functional disorders of the gallbladder and sphincter of Oddi in children are regressed. The unique property of ursodeoxycholic acid in the form of Ukrliv® suspension has been revealed — to affect the activity of microRNA-378f and microRNA-4714-3p generation, which are gene regulators of cellular mechanisms, that influence the gene expression at the post-transcriptional level.
Authors and Affiliations
A. E. Abaturov, V. L. Babich
Keywords
Related Articles
- EP ID EP564685
- DOI 10.22141/2224-0551.14.2.2019.165544
- Views 84
- Downloads 0
Features of the daily blood pressure in children with diabetes depending on the duration of the disease
Background. The presence of hypertension, which in diabetic patients occurs 2 times more often than in the general population, increases the risk of cardiovascular complications. The main tool for the diagnosis of hypert...
Basic Aspects of Studying Risk Factors for Respiratory Diseases in Infants and Preschool Children
The represented review of literature enabled to identify the main factors influencing the development of diseases in infants and preschool children. Knowledge of the various risk factors that contribute to the developme...
Cough: Differential Approaches to Treatment
The article discusses the main differential approaches to treatment of cough, depending on its characteristics and causes.
Significance of Single-Nucleotide Polymorphism rs4769628 in POMP Gene in the Development of Atopic Diseases in Children
The objective of this study was to determine the correlation between single-nucleotide polymorphism rs4769628 in POMP gene and the development of allergic disease in children. Methods. Genotyping of single nucleotide pol...
Angelman Syndrome. Part 3 (Differential Diagnosis and Treatment)
The article discusses the problem of differential diagnosis and treatment of patients with Angelman syndrome (AS). It provides the most common syndromes with similar to AS phenotypes, the main differences between AS-like...